Arias-Stella reaction
A histopathological reaction in the endometrium
The Arias-Stella reaction is a histopathological change observed in the endometrium, typically associated with pregnancy. It is characterized by hypersecretory changes in the endometrial glands, which can be mistaken for endometrial hyperplasia or endometrial carcinoma. This reaction is named after the Peruvian pathologist Javier Arias-Stella, who first described it.
Histopathology[edit]
The Arias-Stella reaction is marked by several distinct histological features. The endometrial glands exhibit nuclear enlargement, hyperchromasia, and cytoplasmic vacuolation. These changes are due to the influence of high levels of human chorionic gonadotropin (hCG) and other hormones during pregnancy.
The nuclei of the glandular cells may appear bizarre and atypical, with prominent nucleoli. The cytoplasm often shows vacuolation and may contain eosinophilic secretions. These changes can mimic those seen in endometrial carcinoma, making accurate diagnosis crucial to avoid unnecessary treatment.
Clinical Significance[edit]
The Arias-Stella reaction is most commonly associated with ectopic pregnancy, but it can also be seen in normal intrauterine pregnancies and molar pregnancy. It is important for pathologists to recognize this reaction to differentiate it from malignant conditions of the endometrium.
Differential Diagnosis[edit]
The differential diagnosis for the Arias-Stella reaction includes:
Accurate diagnosis relies on correlating the histopathological findings with clinical information, such as the presence of pregnancy and levels of hCG.
Related Pages[edit]
Gallery[edit]
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
.jpg){kind=link}